DD273634A5 - Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins - Google Patents
Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins Download PDFInfo
- Publication number
- DD273634A5 DD273634A5 DD88320417A DD32041788A DD273634A5 DD 273634 A5 DD273634 A5 DD 273634A5 DD 88320417 A DD88320417 A DD 88320417A DD 32041788 A DD32041788 A DD 32041788A DD 273634 A5 DD273634 A5 DD 273634A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- solution
- minutes
- filter
- stirred
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10576687A | 1987-10-06 | 1987-10-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD273634A5 true DD273634A5 (de) | 1989-11-22 |
Family
ID=22307671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88320417A DD273634A5 (de) | 1987-10-06 | 1988-10-03 | Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0311366B1 (fi) |
| JP (1) | JP2641745B2 (fi) |
| KR (1) | KR970002637B1 (fi) |
| CN (1) | CN1029966C (fi) |
| AR (1) | AR248407A1 (fi) |
| AT (1) | ATE103916T1 (fi) |
| AU (1) | AU598155B2 (fi) |
| BG (1) | BG47036A3 (fi) |
| CA (1) | CA1334970C (fi) |
| CS (1) | CS270594B2 (fi) |
| DD (1) | DD273634A5 (fi) |
| DE (1) | DE3888913T2 (fi) |
| DK (1) | DK170070B1 (fi) |
| EG (1) | EG18529A (fi) |
| ES (1) | ES2063049T3 (fi) |
| FI (1) | FI884554A (fi) |
| HK (1) | HK15497A (fi) |
| HU (1) | HU206348B (fi) |
| IE (1) | IE62108B1 (fi) |
| IL (1) | IL87905A (fi) |
| MX (1) | MX13277A (fi) |
| MY (1) | MY104063A (fi) |
| NO (1) | NO884416L (fi) |
| NZ (1) | NZ226450A (fi) |
| OA (1) | OA08958A (fi) |
| PH (1) | PH31002A (fi) |
| PL (1) | PL152022B1 (fi) |
| PT (1) | PT88662B (fi) |
| SU (1) | SU1731058A3 (fi) |
| UA (1) | UA19149A (fi) |
| YU (1) | YU46699B (fi) |
| ZA (1) | ZA887409B (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY103554A (en) * | 1987-10-07 | 1993-07-31 | Lilly Co Eli | Manohydrate and solvates of a new (beta)-lactam antibiotic. |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| CA2034592C (en) * | 1990-01-26 | 2001-06-05 | Ralph R. Pfeiffer | Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| US5412094A (en) * | 1993-06-28 | 1995-05-02 | Eli Lilly And Company | Bicyclic beta-lactam/paraben complexes |
| US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
| US6001996A (en) * | 1995-05-11 | 1999-12-14 | Eli Lilly And Company | Complexes of cephalosporins and carbacephalosporins with parabens |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3655656A (en) * | 1970-06-04 | 1972-04-11 | Lilly Co Eli | Crystalline cephalexin monohydrate |
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| MY103554A (en) * | 1987-10-07 | 1993-07-31 | Lilly Co Eli | Manohydrate and solvates of a new (beta)-lactam antibiotic. |
-
1988
- 1988-10-03 CA CA000579158A patent/CA1334970C/en not_active Expired - Fee Related
- 1988-10-03 MY MYPI88001103A patent/MY104063A/en unknown
- 1988-10-03 YU YU184588A patent/YU46699B/sh unknown
- 1988-10-03 ZA ZA887409A patent/ZA887409B/xx unknown
- 1988-10-03 EG EG506/88A patent/EG18529A/xx active
- 1988-10-03 DD DD88320417A patent/DD273634A5/de unknown
- 1988-10-04 DK DK553788A patent/DK170070B1/da active IP Right Grant
- 1988-10-04 FI FI884554A patent/FI884554A/fi not_active Application Discontinuation
- 1988-10-04 IL IL87905A patent/IL87905A/xx active Protection Beyond IP Right Term
- 1988-10-04 NZ NZ226450A patent/NZ226450A/xx unknown
- 1988-10-04 JP JP63251712A patent/JP2641745B2/ja not_active Expired - Fee Related
- 1988-10-04 PH PH37636A patent/PH31002A/en unknown
- 1988-10-04 AU AU23372/88A patent/AU598155B2/en not_active Expired
- 1988-10-04 PT PT88662A patent/PT88662B/pt not_active IP Right Cessation
- 1988-10-04 AR AR88312109A patent/AR248407A1/es active
- 1988-10-04 BG BG85594A patent/BG47036A3/xx unknown
- 1988-10-04 MX MX1327788A patent/MX13277A/es unknown
- 1988-10-05 PL PL1988275093A patent/PL152022B1/pl unknown
- 1988-10-05 ES ES88309261T patent/ES2063049T3/es not_active Expired - Lifetime
- 1988-10-05 UA UA4356543A patent/UA19149A/uk unknown
- 1988-10-05 AT AT88309261T patent/ATE103916T1/de not_active IP Right Cessation
- 1988-10-05 NO NO88884416A patent/NO884416L/no unknown
- 1988-10-05 KR KR1019880012961A patent/KR970002637B1/ko not_active IP Right Cessation
- 1988-10-05 IE IE301588A patent/IE62108B1/en not_active IP Right Cessation
- 1988-10-05 OA OA59444A patent/OA08958A/xx unknown
- 1988-10-05 CN CN88109140A patent/CN1029966C/zh not_active Expired - Lifetime
- 1988-10-05 SU SU884356543A patent/SU1731058A3/ru active
- 1988-10-05 EP EP88309261A patent/EP0311366B1/en not_active Expired - Lifetime
- 1988-10-05 HU HU885171A patent/HU206348B/hu unknown
- 1988-10-05 DE DE3888913T patent/DE3888913T2/de not_active Expired - Lifetime
- 1988-10-06 CS CS886666A patent/CS270594B2/cs not_active IP Right Cessation
-
1997
- 1997-02-05 HK HK15497A patent/HK15497A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT389696B (de) | Verfahren zur herstellung des hydrochloridsalzes des h2-antagonisten n-(2-(((5-(dimethylamino)methyl)-2-furanyl)-methyl)-thio)-|thyl-n1-methy -2-nitro-1,1-aethendiamin | |
| DE3143219C2 (fi) | ||
| DE69811892T2 (de) | Kristalline form von omeprazol-natriumsalz | |
| DE69720774T2 (de) | S-omeprazol in festform | |
| DE2167157C2 (de) | 4-Substituierte-2-halogen-6,7,8-trimethoxychinazoline | |
| DD273634A5 (de) | Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins | |
| DE60004658T2 (de) | Thiazolidindionderivat und seine verwendung als antidiabetikum | |
| DE60004196T2 (de) | Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz | |
| DE3923638A1 (de) | Furanderivate | |
| DE3717080C2 (de) | 1-(Hydroxystyryl)-5H-2,3-benzodiazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE60107074T2 (de) | Kristallin form ii von cabergolin | |
| DE69814076T2 (de) | 8-chlor-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2.b]pyridine polymorphe formen | |
| DE3443065C2 (fi) | ||
| DE69826881T2 (de) | Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain | |
| DE3035259C2 (de) | Cephalosporinverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten | |
| DE2655130C3 (de) | Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes | |
| EP0313935B1 (de) | Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE2234280B2 (de) | Cephalosporinverbindungen und Verfahren zu deren Herstellung | |
| DE2329452A1 (de) | Antibakterielle mittel und verfahren zu deren herstellung | |
| CA2034592C (en) | Crystalline hydrochloride of new beta-lactam antibiotic and process therefor | |
| DE2645144C2 (de) | Cephalosporine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE60130444T2 (de) | Natrium salz eines 5-aminosalicylsäure azoderivates | |
| DE2124249C3 (de) | Trans-2-chlor-l 1 -(3-piperazinyl- propyliden)-6Hdibenz- [b,e] -oxepin, Verfahren zu seiner Herstellung und pharmazeutisches Präparat | |
| DD280112A5 (de) | Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins | |
| AT402069B (de) | Eine neue kristallform des hydrochloridsalzes des h2-antagonisten n-(2-(((5-(dimethylamino)-methyl)-2-furanyl)-me hyl)-thio)-äthyl-n1-methyl-2-nitro- 1, 1-äthendiamin (ranitidin) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF04 | In force in the year 2004 |
Expiry date: 20081004 |